Author: Santus Pierachille Centanni Stefano
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.11, Iss.1, 2002-01, pp. : 49-58
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antileukotrienes in asthma: present situation
By García-Marcos L. Schuster A.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. :
Leukotrienes, Antileukotrienes and Asthma
Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. :
A Risk-Benefit Assessment of Antileukotrienes in Asthma
By Smith L.J.
Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. :
Antileukotrienes as Adjunctive Therapy in Acute Asthma
By Kuitert Lieske M.E. Watson Danie
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma
Drug Safety, Vol. 26, Iss. 7, 2003-01 ,pp. :